| Donald Wesley Grisham, MD | |
|
1100 England Dr, Cookeville, TN 38501-0924 | |
| (931) 528-7531 | |
| (931) 372-2756 |
| Full Name | Donald Wesley Grisham |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 42 Years |
| Location | 1100 England Dr, Cookeville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245290048 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 15257 (Tennessee) | Secondary |
| 208D00000X | General Practice | MD15257 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State Of Tennessee | 5698687077 | 16 |
News Archive
ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, announced today that the company's highly selective oral kinase inhibitor, Telatinib, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of gastric cancer.
Researchers at the University of Granada have found a suicide gene, called 'gene E', which leads to the death of tumour cells derived from breast, lung and colon cancer, and prevents their growth. The importance of this new gene is that its use to fight cancer can reduce the potent drugs that are currently used, so that could mean more effective treatment for cancer.
An Indiana University study published in the September issue of the International Journal of Sexual Health found that women who feel more positively about women's genitals find it easier to orgasm and are more likely to engage in sexual health promoting behaviors, such as having regular gynecological exams or performing vulvar self-examinations.
In an average kindergarten class of 30 students, about two are experiencing developmental language disorder, meaning they learn language more slowly than their peers. While DLD is just as common as dyslexia or ADHD, fewer people have heard of the disorder, and less research and funding go into developing effective interventions.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that data from its Hsp90 chaperone and Hedgehog pathway inhibitor programs will be presented during the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Ill. from June 4 through June 8, 2010.
› Verified 9 days ago
| Entity Name | State Of Tennessee |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487791315 PECOS PAC ID: 5698687077 Enrollment ID: O20031104000309 |
News Archive
ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, announced today that the company's highly selective oral kinase inhibitor, Telatinib, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of gastric cancer.
Researchers at the University of Granada have found a suicide gene, called 'gene E', which leads to the death of tumour cells derived from breast, lung and colon cancer, and prevents their growth. The importance of this new gene is that its use to fight cancer can reduce the potent drugs that are currently used, so that could mean more effective treatment for cancer.
An Indiana University study published in the September issue of the International Journal of Sexual Health found that women who feel more positively about women's genitals find it easier to orgasm and are more likely to engage in sexual health promoting behaviors, such as having regular gynecological exams or performing vulvar self-examinations.
In an average kindergarten class of 30 students, about two are experiencing developmental language disorder, meaning they learn language more slowly than their peers. While DLD is just as common as dyslexia or ADHD, fewer people have heard of the disorder, and less research and funding go into developing effective interventions.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that data from its Hsp90 chaperone and Hedgehog pathway inhibitor programs will be presented during the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Ill. from June 4 through June 8, 2010.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donald Wesley Grisham, MD 1100 England Dr, Cookeville, TN 38501-0924 Ph: (931) 528-7531 | Donald Wesley Grisham, MD 1100 England Dr, Cookeville, TN 38501-0924 Ph: (931) 528-7531 |
News Archive
ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, announced today that the company's highly selective oral kinase inhibitor, Telatinib, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of gastric cancer.
Researchers at the University of Granada have found a suicide gene, called 'gene E', which leads to the death of tumour cells derived from breast, lung and colon cancer, and prevents their growth. The importance of this new gene is that its use to fight cancer can reduce the potent drugs that are currently used, so that could mean more effective treatment for cancer.
An Indiana University study published in the September issue of the International Journal of Sexual Health found that women who feel more positively about women's genitals find it easier to orgasm and are more likely to engage in sexual health promoting behaviors, such as having regular gynecological exams or performing vulvar self-examinations.
In an average kindergarten class of 30 students, about two are experiencing developmental language disorder, meaning they learn language more slowly than their peers. While DLD is just as common as dyslexia or ADHD, fewer people have heard of the disorder, and less research and funding go into developing effective interventions.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that data from its Hsp90 chaperone and Hedgehog pathway inhibitor programs will be presented during the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Ill. from June 4 through June 8, 2010.
› Verified 9 days ago
Trueman David Smith, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 315 N Washington Ave, Suite 265, Cookeville, TN 38501 Phone: 931-854-9432 Fax: 931-854-9434 |